3-[5-(1-Cyclobutylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole

ID: ALA5286989

Max Phase: Preclinical

Molecular Formula: C22H29N5O

Molecular Weight: 379.51

Names and Identifiers

Canonical SMILES:  CC(C)n1nc(-c2nnc(C3CCN(CC4CCC4)CC3)o2)c2ccccc21

Standard InChI:  InChI=1S/C22H29N5O/c1-15(2)27-19-9-4-3-8-18(19)20(25-27)22-24-23-21(28-22)17-10-12-26(13-11-17)14-16-6-5-7-16/h3-4,8-9,15-17H,5-7,10-14H2,1-2H3

Standard InChI Key:  LVIZUKFRUKBLEZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   11.9817  -13.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7664  -13.7753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3743  -13.2238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2020  -12.4174    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4162  -12.1653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8026  -12.7198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8133  -11.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6400  -11.0585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0892  -10.3707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3969   -9.9234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9495  -10.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0827  -16.1411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0815  -16.9678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7957  -17.3803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7939  -15.7287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5087  -16.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5135  -16.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3003  -17.2139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7818  -16.5430    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2925  -15.8778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5596  -17.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0116  -18.6121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3669  -18.1630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5427  -15.0924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3225  -14.8335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3177  -14.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5322  -13.7592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0517  -14.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  8  1  0
 12 13  2  0
 13 14  1  0
 14 17  2  0
 16 15  2  0
 15 12  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 18 21  1  0
 21 22  1  0
 21 23  1  0
 20 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  2  0
 26  1  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5286989

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 379.51

Molecular Weight (Monoisotopic): 379.2372

AlogP: 4.65

#Rotatable Bonds: 5

Polar Surface Area: 59.98

Molecular Species: BASE

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.31

CX LogP: 3.42

CX LogD: 1.51

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.65

Np Likeness Score: -1.43

References

1. Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V..  (2021)  Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT₄ Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease.,  64  (15.0): [PMID:34251799] [10.1021/acs.jmedchem.1c00703]

Source

Source(1):

• Scientific Literature